A protocol designed to progressively increase physical therapy intensity for stroke survivors improved walking distance, ...

Atai Life Sciences N.V. reported positive top-line phase 2a results of BPL-003 in treating Alcohol Use Disorder patients.

Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...

William Blair reiterated their outperform rating on shares of Encompass Health (NYSE:EHC – Free Report) in a report published ...

Results showed combined medial patellofemoral ligament and medial quadriceps tendon femoral ligament reconstruction may yield ...

In a report released on January 28, Tom Callaghan from RBC Capital initiated coverage with a Hold rating on Extendicare (EXE – Research Report) ...

Shares of Encompass Health Co. (NYSE:EHC – Get Free Report) gapped up before the market opened on Friday after the company announced better than expected quarterly earnings. The stock had previously ...

Each of the RSU grants vests ratably in equal installments on the first, second, and third anniversaries of the grant date, subject to the recipient's continued service with the Company through the ...

JMP Securities reiterated their Market Outperform rating on Solid Biosciences (NASDAQ:SLDB) with a steady price target of $15.00. Currently trading at $3.04, the company has a market capitalization of ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to ...